rofecoxib has been researched along with Bile Duct Obstruction in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"Rofecoxib is a member of the coxib family of nonsteroidal anti-inflammatory drugs that selectively inhibit cyclooxygenase-2." | 1.33 | Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs. ( Leung, Y; Myers, RP; Urbanski, SJ; Yan, B, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huster, D | 1 |
Schubert, C | 1 |
Berr, F | 1 |
Mössner, J | 1 |
Caca, K | 1 |
Papachristou, GI | 1 |
Demetris, AJ | 1 |
Rabinovitz, M | 1 |
Linares, P | 1 |
Vivas, S | 1 |
Jorquera, F | 1 |
Olcoz, JL | 1 |
de Leon, B | 1 |
Oritz de Urbina, J | 1 |
Ouar, S | 1 |
Bellaïche, G | 1 |
Belloc, J | 1 |
Tordjman, G | 1 |
Ley, G | 1 |
Slama, JL | 1 |
Yan, B | 1 |
Leung, Y | 1 |
Urbanski, SJ | 1 |
Myers, RP | 1 |
5 other studies available for rofecoxib and Bile Duct Obstruction
Article | Year |
---|---|
Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Female; Hepatitis; Humans; Lactones; Liver, Ar | 2002 |
Acute cholestatic hepatitis associated with long-term use of rofecoxib.
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclooxygenase Inhibitors; | 2004 |
Severe cholestasis and acute renal failure related to rofecoxib.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Cyclooxygenase Inhi | 2004 |
[Severe acute cholestatic and cytolytic hepatitis induced by rofecoxib].
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclooxygenase Inhibitors; | 2005 |
Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.
Topics: Adult; Arthritis; Biopsy; Cholestasis; Cyclooxygenase 2 Inhibitors; Female; Follow-Up Studies; Human | 2006 |